A Win For Co-Diagnostics, Inc.
Thu, Jul 22, 2021 at 05:30 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) shot up at $10.54, representing a gain of 21.1%. On Wed, Jul 21, 2021, CODX:NASDAQ hit a New 2-Week High of $8.7. The stock appeared on our News Catalysts scanner on Thu, Jul 22, 2021 at 10:25 AM in the 'PATENT' category. From Wed, Jul 07, 2021, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Tue, Feb 09, 2021 at $20.69 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- IPA (IPA:NASDAQ), 138.2%
- India Globalization Capital, Inc. (IGC:NYSEMKT), 89.19%
- NRXP (NRXP:NASDAQ), 62.71%
- UPC (UPC:NASDAQ), 44.53%
- SigmaTron International, Inc. (SGMA:NASDAQ), 29.96%
- PRFX (PRFX:NASDAQ), 29.94%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 21.15%
- NeuroMetrix, Inc. (NURO:NASDAQ), 18.89%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 18.03%